| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An Exploratory Study of Alternative Time Frames and Descriptors for EQ-5D-5L in Obstructive Airway Diseases Using Mixed Methods
|
Chua, Ai-Ping
|
|
|
27 |
11 |
p. 1564-1572
|
artikel
|
| 2 |
Assessing the Health and Welfare Benefits of Interventions Using the Wider Societal Impacts Framework
|
Premji, Shainur
|
|
|
27 |
11 |
p. 1479-1487
|
artikel
|
| 3 |
Attribute Development in Health-Related Discrete Choice Experiments: A Systematic Review of Qualitative Methods and Techniques to Inform Quantitative Instruments
|
Bohorquez, Natalia Gonzalez
|
|
|
27 |
11 |
p. 1620-1633
|
artikel
|
| 4 |
Choice Consistency in Discrete Choice Experiments: Does Numeracy Skill Matter?
|
Genie, Mesfin G.
|
|
|
27 |
11 |
p. 1594-1604
|
artikel
|
| 5 |
Clinical Outcome Assessments Are Never “Validated”
|
Zigler, Christina K.
|
|
|
27 |
11 |
p. 1494-1496
|
artikel
|
| 6 |
Development of a Prioritization Framework to Aid Healthcare Funding Decision Making in Health Technology Assessment in Australia: Application of Multicriteria Decision Analysis
|
Khanal, Saval
|
|
|
27 |
11 |
p. 1585-1593
|
artikel
|
| 7 |
Editorial Board
|
|
|
|
27 |
11 |
p. v
|
artikel
|
| 8 |
EQ-5D-5L Population Scores in Mainland China: Results From a Nationally Representative Survey 2021
|
Yao, Qiang
|
|
|
27 |
11 |
p. 1573-1584
|
artikel
|
| 9 |
First-Line Treatment With Atezolizumab Plus Bevacizumab and Chemotherapy for US Patients With Metastatic, Persistent, or Recurrent Cervical Cancer: A Cost-Effectiveness Analysis
|
Lei, Jianying
|
|
|
27 |
11 |
p. 1528-1534
|
artikel
|
| 10 |
How Many Monte Carlo Samples Are Needed for Probabilistic Cost-Effectiveness Analyses?
|
Yaesoubi, Reza
|
|
|
27 |
11 |
p. 1553-1563
|
artikel
|
| 11 |
Informing the United States Medicare Drug Price Negotiation for Apixaban and Rivaroxaban: Methodological Considerations for Value Assessments Many Years After Launch
|
Richardson, Marina
|
|
|
27 |
11 |
p. 1507-1514
|
artikel
|
| 12 |
Key Issues of Economic Evaluations for Health Technology Assessment in China: A Nationwide Expert Survey
|
Liu, Gordon G.
|
|
|
27 |
11 |
p. 1535-1543
|
artikel
|
| 13 |
Linking Reimbursement to Patient Benefits for Advanced Therapy Medicinal Products and Other High-Cost Innovations: Policy Recommendations for Outcomes-Based Agreements in Europe
|
Avşar, Tuba Saygın
|
|
|
27 |
11 |
p. 1497-1506
|
artikel
|
| 14 |
Measuring Healthcare Experiences Among People With Intellectual Disability: A Rapid Evidence Synthesis of Tools and Methods
|
Harrison, Reema
|
|
|
27 |
11 |
p. 1605-1619
|
artikel
|
| 15 |
Recommendations on the Use of Structured Expert Elicitation Protocols for Healthcare Decision Making: A Good Practices Report of an ISPOR Task Force
|
Soares, Marta
|
|
|
27 |
11 |
p. 1469-1478
|
artikel
|
| 16 |
Table of Contents
|
|
|
|
27 |
11 |
p. i-iv
|
artikel
|
| 17 |
The Cost-Effectiveness of Germline BReast CAncer Gene Testing in Metastatic Prostate Cancer Followed by Cascade Testing of First-Degree Relatives of Mutation Carriers
|
Teppala, Srinivas
|
|
|
27 |
11 |
p. 1515-1527
|
artikel
|
| 18 |
Valuation of Multidimensional Health States With a Bolt-On: Is There a Shortcut?
|
Yang, Zhihao
|
|
|
27 |
11 |
p. 1544-1552
|
artikel
|
| 19 |
When Are You Recovered? Defining Cutoff Points Using the Acute Respiratory Tract Infection Questionnaire
|
Johansen, Eskild
|
|
|
27 |
11 |
p. 1488-1493
|
artikel
|
Tijdschrift beschrijving